Skip to content

Patient Square Capital LP: KYMR position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Patient Square Capital LP on KYMR, newest first. How the timeline and the estimate are built.

Patient Square Capital LP held 47,500 KYMR shares at 2026-06-30 per its 13F-HR filed 2026-08-12.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 47,500 shares
    Change vs previous 13F -52,500 shares

    0.84% of the 13F portfolio, value $5,446,825.

    13F-HR 0001819257-26-000005 filed by Patient Square Capital LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 100,000 shares
    Change vs previous 13F -39,000 shares

    1.48% of the 13F portfolio, value $8,329,000.

    13F-HR 0001819257-26-000003 filed by Patient Square Capital LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 139,000 shares
    Change vs previous 13F +46,408 shares

    2.32% of the 13F portfolio, value $10,815,590.

    13F-HR 0001819257-26-000002 filed by Patient Square Capital LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 92,592 shares
    Change vs previous 13F -47,408 shares

    1.4% of the 13F portfolio, value $5,240,707.

    13F-HR 0001819257-25-000002 filed by Patient Square Capital LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 140,000 shares
    Change vs previous 13F -2,201 shares

    2.2% of the 13F portfolio, value $6,109,600.

    13F-HR 0000950123-25-007478 filed by Patient Square Capital LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2025-03-31
    13F 142,201 shares
    Change vs previous 13F not available

    1.61% of the 13F portfolio, value $3,892,041.

    13F-HR 0000950123-25-005195 filed by Patient Square Capital LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).